Paper Review Records
全部论文审稿周期
14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
176
天
FABP4+ macrophages promote glycolysis in lung cancer progression through the TNF-α–MYC pathway
作者
Lingwei Liu; Weibin Shu; Chuanxi Wang; Qiang Wen; Hongchang Shen; Qiang Li; Keying Che展开收起
作者单位
1. Department of Nuclear Medicine, Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, China; 2. Tumor Research and Therapy Center, Shandong Provincial Hospital, Affiliated to Shandong First Medical University, Jinan, China展开收起
149
天
Dendritic cells enhance tebentafusp-mediated T cell effector responses
作者
Manuel Wiesinger; Anne Petzold; Markus Luber; Philipp Hilgendorf; Andreas Wild; Markus Vincent Heppt; Beatrice Schuler‐Thurner; Kilian Schober; Carola Berking; Elias A. T. Koch展开收起
作者单位
1. Friedrich-Alexander-Universität Erlangen-Nürnberg; 2. Universitätsklinikum Erlangen; 3. Comprehensive Cancer Center Erlangen展开收起
34
天
Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis
作者
K. E. Blethen; C. P. Wolford; G. L. Pecar; T. A. Arsiwala; E. Adjeroh; L. P. Dykstra; B. N. Kielkowski; P. R. Lockman展开收起
作者单位
1. Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, USA; 2. Rockefeller Neuroscience Institute, West Virginia University, Morgantown, USA展开收起
134
天
Phellinus linteus activates Treg cells via FAK to promote M2 macrophage polarization in hepatocellular carcinoma
作者
Feihua Chen; Mouchun Gong; Dengcheng Weng; Zhaoqing Jin; Guofeng Han; Ziqiang Yang; Junjun Han; Jianjiang Wang展开收起
作者单位
1. Department of General Surgery, Hangzhou Medical College Affiliated Lin’an People’s Hospital, Hangzhou, China展开收起
34
天
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment
作者
Joanna Baginska; Allison Nau; Ilana Gomez Diaz; Anita Giobbie-Hurder; Jason Weirather; Juliana Vergara; Charlotte Abrecht; Margaret Hallisey; Jenna Dennis; Mariano Severgnini; Julia Huezo; Isabella Marciello; Osama Rahma; Michael Manos; Andrew S. Brohl; Philippe L. Bedard; Daniel J. Renouf; Elad Sharon; Howard Streicher; Patrick A. Ott; Elizabeth I. Buchbinder; F. Stephen Hodi展开收起
作者单位
1. Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, USA; 2. Department of Data Science, Dana-Farber Cancer Institute, Boston, USA; 3. Sarcoma Department and Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA; 4. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; 5. Cancer and Department of Medicine, University of British Columbia, Vancouver, Canada; 6. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, USA展开收起
35
天
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice
作者
Akashdip Singh; Eline T. A. M. Mommers-Elshof; Saskia V. Vijver; J. H. Marco Jansen; Susanne Gonder; Robert Jan Lebbink; Dominique Bihan; Richard W. Farndale; Louis Boon; Solomon Langermann; Jeanette H. W. Leusen; Dallas Flies; Linde Meyaard; M. Ines Pascoal Ramos展开收起
作者单位
1. Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands; 2. Oncode Institute, Utrecht, The Netherlands; 3. Department of Biochemistry, University of Cambridge, Cambridge, UK; 4. JJP Biologics, Warsaw, Poland; 5. Nextcure, Beltsville, USA展开收起
FAQ
CANCER IMMUNOLOGY IMMUNOTHERAPY审稿要多久?
截至2026-11-19,CrushSCI 收录了 CANCER IMMUNOLOGY IMMUNOTHERAPY 的 14 篇完整审稿记录。最快一篇从收稿到录用用了 34 天(Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis,2023-10-03 收稿,2023-11-06 录用),最慢一篇用了 176 天;平均 85.9 天,中位数 64 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
